See up to 3 months of MNPR. The 7-day demo opens the 1M and 3M ranges and puts MNPR on your watchlist.
Start 7-day demoLatest MNPR insider trades
About Monopar Therapeutics (MNPR)
Monopar Therapeutics is an SEC registrant, filing under CIK 0001645469, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
MNPR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 26 | 51,921 | $4.83M |
| Option exercise | 22 | 121,734 | |
| Tax withholding / forfeiture | 3 | 6,468 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MNPR insider transactions (Form 4)
9831 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christopher M. Starr - Director | Option exercise | Common Stock | 8,400 | $0.01 | $42 | |
| Christopher M. Starr - Director | Open-market sale | Common Stock | 4,631 | $78.09 footnote F4 | $362K | |
| Christopher M. Starr - Director | Open-market sale | Common Stock | 2,970 | $78.82 footnote F5 | $234K | |
| Christopher M. Starr - Director | Open-market sale | Common Stock | 799 | $79.67 footnote F6 | $64K | |
| Christopher M. Starr - Director | Option exercise | Stock Option | 8,400 | $0.00 | - | |
| ||||||
| Andrew Cittadine - Officer | Option exercise | Common Stock | 4,384 | - footnote F1 | - | |
| Andrew Cittadine - Officer | Tax withholding / forfeiture | Common Stock | 1,944 footnote F2 | $79.67 | $155K | |
| Andrew Cittadine - Officer | Option exercise | Restricted Stock Unit | 4,384 | $0.00 | - | |
| ||||||
| Chandler Robinson - Officer | Option exercise | Common Stock | 9,801 | - footnote F1 | - | |
| Chandler Robinson - Officer | Tax withholding / forfeiture | Common Stock | 4,344 footnote F2 | $79.67 | $346K | |
| Chandler Robinson - Officer | Option exercise | Restricted Stock Unit | 9,801 | $0.00 | - | |
| ||||||
| Quan Anh Vu - Officer | Option exercise | Common Stock | 614 | - footnote F1 | - | |
| Quan Anh Vu - Officer | Tax withholding / forfeiture | Common Stock | 180 footnote F2 | $79.67 | $14K | |
| Quan Anh Vu - Officer | Option exercise | Restricted Stock Unit | 614 | $0.00 | - | |
| ||||||
| Chandler Robinson - Officer | Option exercise | Common Stock | 14,056 | $30.00 | $422K | |
| Chandler Robinson - Officer | Option exercise | Common Stock | 15,000 | $14.00 | $210K | |
| Chandler Robinson - Officer | Open-market sale | Common Stock | 10,450 | $87.15 footnote F5 | $911K | |
| Chandler Robinson - Officer | Open-market sale | Common Stock | 9,638 | $87.96 footnote F6 | $848K | |
| Chandler Robinson - Officer | Open-market sale | Common Stock | 8,368 | $88.97 footnote F7 | $745K | |
| Chandler Robinson - Officer | Open-market sale | Common Stock | 600 | $89.79 footnote F8 | $54K | |
| Chandler Robinson - Officer | Option exercise | Stock Option | 14,056 | $0.00 | - | |
| Chandler Robinson - Officer | Option exercise | Stock Option | 15,000 | $0.00 | - | |
| ||||||
 Kim R. Tsuchimoto - Director | Option exercise | Common Stock | 2,055 | $30.00 | $62K | |
| Kim R. Tsuchimoto - Director | Option exercise | Common Stock | 2,035 | $14.00 | $28K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 485 | $108.83 footnote F4 | $53K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 615 | $109.56 footnote F5 | $67K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 700 | $110.65 footnote F6 | $77K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 1,098 | $111.84 footnote F7 | $123K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 602 | $112.93 footnote F8 | $68K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 590 | $113.84 footnote F9 | $67K | |
| Kim R. Tsuchimoto - Director | Option exercise | Stock Option | 2,055 | $0.00 | - | |
| Kim R. Tsuchimoto - Director | Option exercise | Stock Option | 2,035 | $0.00 | - | |
| ||||||
| Raymond Anderson - Director | Option exercise | Common Stock | 1,402 | $30.00 | $42K | |
| Raymond Anderson - Director | Option exercise | Common Stock | 1,740 | $30.00 | $52K | |
| Raymond Anderson - Director | Open-market sale | Common Stock | 694 | $110.04 footnote F4 | $76K | |
| Raymond Anderson - Director | Open-market sale | Common Stock | 646 | $111.07 footnote F5 | $72K | |
| Raymond Anderson - Director | Open-market sale | Common Stock | 1,802 | $113.05 footnote F6 | $204K | |
| Raymond Anderson - Director | Option exercise | Stock Option | 1,402 | $0.00 | - | |
| Raymond Anderson - Director | Option exercise | Stock Option | 1,740 | $0.00 | - | |
| ||||||
| Patrice Rioux | Option exercise | Common Stock | 1,380 | $0.01 | $7 | |
| Patrice Rioux | Open-market sale | Common Stock | 1 | $111.26 | $111 | |
| Patrice Rioux | Option exercise | Stock Option | 1,380 | $0.00 | - | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 485 | $108.83 footnote F2 | $53K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 615 | $109.56 footnote F3 | $67K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 700 | $110.65 footnote F4 | $77K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 1,098 | $111.84 footnote F5 | $123K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 602 | $112.93 footnote F6 | $68K | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 590 | $113.84 footnote F7 | $67K | |
| ||||||
| Raymond Anderson - Director | Open-market sale | Common Stock | 694 | $110.04 footnote F2 | $76K | |
| Raymond Anderson - Director | Open-market sale | Common Stock | 646 | $110.07 footnote F3 | $71K | |
| Raymond Anderson - Director | Open-market sale | Common Stock | 1,802 | $113.05 footnote F4 | $204K | |
| ||||||
| Quan Anh Vu - Officer | Option exercise | Common Stock | 1,228 | - footnote F1 | - | |
| Quan Anh Vu - Officer | Tax withholding / forfeiture | Common Stock | 507 footnote F2 | $92.59 | $47K | |
| Quan Anh Vu - Officer | Option exercise | Restricted Stock Unit | 1,228 | $0.00 | - | |
| ||||||
| Chandler Robinson - Officer | Option exercise | Common Stock | 12,873 | - footnote F1 | - | |
| Chandler Robinson - Officer | Tax withholding / forfeiture | Common Stock | 4,084 footnote F2 | $92.59 | $378K | |
| Chandler Robinson - Officer | Option exercise | Restricted Stock Unit | 12,873 | $0.00 | - | |
| ||||||
| Andrew Cittadine - Officer | Option exercise | Common Stock | 5,254 | - footnote F1 | - | |
| Andrew Cittadine - Officer | Tax withholding / forfeiture | Common Stock | 2,309 footnote F2 | $92.59 | $214K | |
| Andrew Cittadine - Officer | Option exercise | Restricted Stock Unit | 5,254 | $0.00 | - | |
| ||||||
 Nicole Sweeny - Director | Grant or award | Stock Options | 1,284 | $0.00 | - | |
| Chandler Robinson - Officer | Option exercise | Common Stock | 6,732 | - footnote F1 | - | |
| Chandler Robinson - Officer | Tax withholding / forfeiture | Common Stock | 1,972 footnote F2 | $54.79 | $108K | |
| Chandler Robinson - Officer | Option exercise | Restricted Stock Unit | 6,732 | $0.00 | - | |
| ||||||
| Andrew Cittadine - Officer | Option exercise | Common Stock | 3,514 | - footnote F1 | - | |
| Andrew Cittadine - Officer | Tax withholding / forfeiture | Common Stock | 1,571 footnote F2 | $54.79 | $86K | |
| Andrew Cittadine - Officer | Option exercise | Restricted Stock Unit | 3,514 | $0.00 | - | |
| ||||||
| Susan Rodriguez - Officer | Grant or award | Stock Options | 48,728 | $0.00 | - | |
| Chandler Robinson - Officer | Other | Common Stock | 62,815 | $0.00 | - | |
| Andrew Cittadine - Officer | Option exercise | Common Stock | 4,327 | - | - | |
| Andrew Cittadine - Officer | Tax withholding / forfeiture | Common Stock | 1,896 | $81.67 | $155K | |
| Andrew Cittadine - Officer | Option exercise | Restricted Stock Units | 4,327 | $0.00 | - | |
| Chandler Robinson - Officer | Option exercise | Common Stock | 8,726 | - | - | |
| Chandler Robinson - Officer | Tax withholding / forfeiture | Common Stock | 2,646 | $81.67 | $216K | |
| Chandler Robinson - Officer | Option exercise | Restricted Stock Units | 8,726 | $0.00 | - | |
| Tactic Pharma LLC - 10% Owner | Open-market sale | Common Stock | 550,229 | $63.61 | $35.00M | |
| Chandler Robinson - Officer | Other | Common Stock | 16,800 | $0.01 | $84 | |
| Chandler Robinson - Officer | Open-market sale | Common Stock | 16,800 | $40.00 | $672K | |
| Chandler Robinson - Officer | Other | Stock Options | 16,800 | $0.00 | - | |
| Kim R. Tsuchimoto - Director | Other | Common Stock | 8,904 | $0.01 | $45 | |
| Kim R. Tsuchimoto - Director | Open-market sale | Common Stock | 8,904 | $40.00 | $356K | |
| Kim R. Tsuchimoto - Director | Other | Stock Options | 4,200 | $0.00 | - | |
| Kim R. Tsuchimoto - Director | Other | Stock Options | 4,704 | $0.00 | - | |
| Christopher M. Starr - Director | Other | Common Stock | 16,800 | $0.01 | $84 | |
| Christopher M. Starr - Director | Open-market sale | Common Stock | 16,800 | $40.00 | $672K | |
| Christopher M. Starr - Director | Other | Stock Options | 16,800 | $0.00 | - | |
| Chandler Robinson - Officer | Option exercise | Common Stock | 13,344 | - | - | |
| Chandler Robinson - Officer | Tax withholding / forfeiture | Common Stock | 5,865 | $35.78 | $210K | |
| Chandler Robinson - Officer | Option exercise | Restricted Stock Units | 13,344 | $0.00 | - | |
| Andrew Cittadine - Officer | Option exercise | Common Stock | 6,863 | - | - | |
| Andrew Cittadine - Officer | Tax withholding / forfeiture | Common Stock | 2,990 | $35.78 | $107K | |
| Andrew Cittadine - Officer | Option exercise | Restricted Stock Units | 6,863 | $0.00 | - | |
| Tactic Pharma LLC - 10% Owner | Open-market sale | Common Stock | 33,334 | $35.00 | $1.17M | |
| TacticGem LLC - 10% Owner | Other | Common Stock | 1,433,334 | $0.00 | - | |
| Karthik Radhakrishnan - Officer | Open-market purchase | Common Stock | 1,550 | $16.25 | $25K | |
| Chandler Robinson - Officer | Option exercise | Common Stock | 4,895 | - | - | |
| Chandler Robinson - Officer | Tax withholding / forfeiture | Common Stock | 1,918 | $6.74 | $13K | |
| Chandler Robinson - Officer | Option exercise | Restricted Stock Units | 4,895 | $0.00 | - | |
Item 2.02, 9.01
Item 7.01, 9.01
Item 7.01, 9.01
Item 7.01, 9.01
Recent MNPR Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| CHRISTOPHER STARR | Director | 16,800 | $1.34M | View on EDGAR | |
| CHANDLER ROBINSON | Director, Officer | 29,056 |
MNPR insider trading FAQ
What is the latest insider trade for MNPR?
Monopar Therapeutics (MNPR) had 10 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for MNPR runs to 31 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MNPR stock?
No insider purchases of MNPR were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling MNPR stock?
26 insider sales of MNPR were filed in the last 90 days, totaling $4.83M.
Where can I see MNPR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MNPR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Christopher M. Starr view on EDGAR
- - Andrew Cittadine view on EDGAR
- - Chandler Robinson view on EDGAR
- - Quan Anh Vu view on EDGAR
- - Chandler Robinson view on EDGAR
- - Kim R. Tsuchimoto view on EDGAR
- - Raymond Anderson view on EDGAR
- - Patrice Rioux view on EDGAR
- - Kim R. Tsuchimoto view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where MNPR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MNPR with a 7-day demo
- MNPR on your watchlist
- Every MNPR Form 4 filing on record
- Up to 3 months of MNPR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
